3 ms·
There is definitely an element of US self-interest. The US invests a disproportionate amount of capital into R&D relative to its GDP compared to other countries
by jandrewrogers 14y ago
There is definitely an element of US self-interest. The US invests a disproportionate amount of capital into R&D relative to its GDP compared to other countries and also reaps a disproportionate result from that R&D investment (i.e. US R&D investments tend to have a higher return per dollar invested compared to most countries).
I have a strong self-interest in making sure effective R&D happens: computers, biomedical, etc. I don't care where that investment happens for the most part. In terms of maximizing R&D output for the currency invested, US has been the clear leaders for a long time. I am less concerned with why the US is producing so much high-value R&D than with why so few other countries are producing anything comparable. A few European countries do produce similar results on a per capita basis but the tend to be outliers with tiny populations that don't add up to much in absolute terms.
- cturner 14y agoTwo things. R&D is not a generic, fungible thing. R&D that occurs in a patent environment will have a different focus than R&D that occurs without. I'd expect funding spent on lawyers writing defencive patent proposals would be figured on the balance sheet as R&D, even though it isn't. Or R&D spent finding new ways to extend existing patent rights of a drug. Or finding ways to innovate without breaching competitors' patents. Secondly, there's no evidence to demonstrate that the amount of R&D that happens with patents is more than there would be without patents. I think you're focussed on the upside - companies that do some more work because of protection. But that needs to be balanced against the amount of research and development that isn't done because of the increased barriers to entry.